Weekly Sepsis Research Analysis
This week’s sepsis literature highlighted mechanistic advances in inflammatory cell death and organ injury, alongside growing efforts toward precision diagnosis and risk stratification. Preclinical studies identified DDX3x–histone lactylation–NINJ1 signaling in sepsis-associated acute kidney injury, Cul4B-mediated NLRP3 ubiquitination in lung injury, and an astrocyte-derived LCN2–24p3R pathway in sepsis-associated encephalopathy. Clinical and translational studies emphasized phenotype-guided ped
Summary
This week’s sepsis literature highlighted mechanistic advances in inflammatory cell death and organ injury, alongside growing efforts toward precision diagnosis and risk stratification. Preclinical studies identified DDX3x–histone lactylation–NINJ1 signaling in sepsis-associated acute kidney injury, Cul4B-mediated NLRP3 ubiquitination in lung injury, and an astrocyte-derived LCN2–24p3R pathway in sepsis-associated encephalopathy. Clinical and translational studies emphasized phenotype-guided pediatric trials, dynamic kidney-function monitoring, explainable artificial intelligence, and cautious interpretation of transfusion and biomarker strategies. The major paradigm shift is the movement from nonspecific sepsis treatment toward biologically defined organ-specific mechanisms and longitudinal patient phenotypes, although most novel interventions remain preclinical.
Selected Articles
1. DDX3x Regulates NINJ1 Transcription via Histone Lactylation in Sepsis Associated-Acute Kidney Injury.
This mechanistic study identified a DDX3x–histone lactylation–NINJ1 pathway linking lactate accumulation to PANoptosis and tubular injury in sepsis-associated acute kidney injury. DDX3x functioned as a previously unrecognized delactylase, and its agonist Odetiglucan reduced histone lactylation, NINJ1 transcription, PANoptosis, and kidney injury in cultured renal cells and cecal ligation and puncture mice.
Impact: The paper provides a multilevel causal mechanism and pharmacologic proof of concept for a major sepsis complication. It identifies an actionable epigenetic pathway rather than merely describing an inflammatory association.
Clinical Implications: DDX3x-enhancing therapies could eventually become targeted treatment for sepsis-associated acute kidney injury, but Odetiglucan requires validation of pharmacokinetics, safety, organ selectivity, therapeutic timing, and efficacy in larger models before human trials.
Key Findings
- Lactate-induced H3K9/18/27 histone lactylation increased NINJ1 transcription and PANoptosis.
- DDX3x was identified as a delactylase regulating histone lactylation and NINJ1 expression.
- Odetiglucan reduced kidney injury in cellular and murine sepsis-associated acute kidney injury models.
2. Cul4B up-regulation attenuates sepsis-induced acute lung injury by promoting NLRP3 ubiquitination and inhibiting NLRP3 inflammasome activation.
This study showed that Cul4B is downregulated in sepsis-induced acute lung injury and protects the lung by interacting with NLRP3 and promoting its ubiquitination. Lung-specific Cul4B overexpression reduced inflammation and barrier damage, whereas myeloid Cul4B deletion worsened injury; the small molecule MN-08 increased Cul4B and protected against experimental lung injury.
Impact: The paper establishes Cul4B-dependent NLRP3 ubiquitination as a regulatory checkpoint for sepsis lung injury and connects the mechanism to a drug-like compound. This creates a coherent target-to-therapy pathway for a common and lethal sepsis complication.
Clinical Implications: Cul4B–NLRP3 signaling may support development of targeted therapies for sepsis-induced acute lung injury, but MN-08 requires testing for survival benefit, antimicrobial-defense effects, dose, toxicity, and efficacy in human-relevant models.
Key Findings
- Cul4B expression was reduced in two mouse models of sepsis-induced acute lung injury.
- Cul4B overexpression protected the lung, while myeloid-specific deletion aggravated inflammation and barrier damage.
- Cul4B promoted NLRP3 ubiquitination, and MN-08 increased Cul4B expression and suppressed inflammasome activation.
3. Astrocytic LCN2 mediates pathological crosstalk with neurons to promote neuronal loss in sepsis-associated encephalopathy.
Using lipopolysaccharide and cecal ligation and puncture models, this study identified an astrocyte-to-neuron LCN2–24p3R–mTOR–ULK1 pathway in sepsis-associated encephalopathy. Astrocytic LCN2 activated neuronal 24p3R and mTOR signaling, suppressed autophagy, and promoted mitochondrial damage, synaptic dysfunction, neuronal loss, and cognitive impairment; receptor knockdown or mTOR inhibition improved these abnormalities.
Impact: The study expands sepsis research beyond peripheral organ failure by defining a mechanistic glial-neuronal pathway for neurological injury and cognitive dysfunction. It provides multiple experimentally testable intervention points in a clinically important but poorly treated complication.
Clinical Implications: LCN2, neuronal 24p3R, or mTOR could become targets for preventing sepsis-associated encephalopathy, but translation requires confirmation in human disease, clinically accessible biomarkers, definition of treatment timing, and assessment of neurological safety.
Key Findings
- Astrocyte-derived LCN2 increased in the hippocampus and correlated with neuronal loss and cognitive impairment.
- Neuronal 24p3R activated mTOR–ULK1 signaling, suppressed autophagy, and promoted mitochondrial and synaptic injury.
- 24p3R knockdown or mTOR inhibition improved neuronal survival, synaptic function, and cognitive outcomes in experimental sepsis.